Duaklir Genuair, the latest dry powder inhaler for COPD

Duaklir Genuair is a twice daily dry powder inhaler licensed as maintenance therapy for COPD. Here we present the clinical data relating to its efficacy and adverse events and discuss its place in therapy.

Duaklir Genuair the latest dry powder inhaler for COPD

Add yours ↓
Web design and marketing agency Leamington Spa